Radiolabeled mAbs as Molecular Imaging and/or Therapy Agents Targeting PSMA

被引：12

作者：

Psimadas, Dimitrios ^{[1
]}

Valotassiou, Varvara ^{[1
]}

Alexiou, Sotiria ^{[1
]}

Tsougos, Ioannis ^{[1
]}

Georgoulias, Panagiotis ^{[1
]}

机构：

[1] Univ Thessaly, Sch Med, Univ Hosp Larissa, Dept Nucl Med, Larisa, Greece

来源：

CANCER INVESTIGATION | 2018年 / 36卷 / 02期

关键词：

Antibodies; radiolabeling; PSMA; prostate cancer; LU-177-PSMA-617 RADIOLIGAND THERAPY; METASTATIC PROSTATE-CANCER; MEMBRANE ANTIGEN PSMA; MONOCLONAL-ANTIBODY J591; IN-VIVO; PRECLINICAL EVALUATION; EXTRACELLULAR DOMAIN; RADIATION-DOSIMETRY; INHIBITORS; TUMORS;

D O I：

10.1080/07357907.2018.1430816

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Molecular imaging and therapy is a rapidly evolving field in research and clinical medicine. The use of the exciting and attractive properties of radioisotopes for imaging and therapy has made Nuclear Medicine very significant when it comes to molecular imaging/therapy. Monoclonal Antibodies (mAbs) on the other hand are very important targeting biomolecules with high affinity that can "carry" the radioisotope of choice. Herein we make a brief overview of the radiolabeled mAbs that target prostate specific membrane antigen (PSMA) and their use in the management of patients with prostate cancer (PCa).

引用

页码：118 / 128

页数：11

共 50 条

[1] Current Status of Radiolabeled Monoclonal Antibodies Targeting PSMA for Imaging and Therapy
Abusalem, Mohammed
Martiniova, Lucia
Soebianto, Sarita
Depalatis, Louis
Ravizzini, Gregory
CANCERS, 2023, 15 (18)
[2] Radiolabeled enzyme inhibitors and binding agents targeting PSMA: Effective theranostic tools for imaging and therapy of prostate cancer
Pillai, Maroor Raghavan Ambikalmajan
Nanabala, Raviteja
Joy, Ajith
Sasikumar, Arun
Knapp, Fum F.
NUCLEAR MEDICINE AND BIOLOGY, 2016, 43 (11) : 692 - 720
[3] Radiopharmaceuticals targeting PSMA for imaging and/or therapy
Morgat, C.
Gallerande, H. de Clermont
Fernandez, P.
Hindie, E.
MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2019, 43 (03): : 284 - 286
[4] TARGETING OF CANCER WITH RADIOLABELED ANTIBODIES - PROSPECTS FOR IMAGING AND THERAPY
GOLDENBERG, DM
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1988, 112 (06) : 580 - 587
[5] Molecular imaging and therapy of cancer with radiolabeled nanoparticles
Hong, Hao
Zhang, Yin
Sun, Jiangtao
Cai, Weibo
NANO TODAY, 2009, 4 (05) : 399 - 413
[6] The utility of radiolabeled PSMA ligands for tumor imaging
Shahrokhi, Pejman
Masteri Farahani, Arezou
Tamaddondar, Mohammad
Rezazadeh, Farzaneh
CHEMICAL BIOLOGY & DRUG DESIGN, 2022, 99 (01) : 136 - 161
[7] Radiolabeled nanobodies for tumor targeting: From bioengineering to imaging and therapy
Piramoon, Majid
Khodadust, Fatemeh
Hosseinimehr, Seyed Jalal
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2021, 1875 (02):
[8] Generation and characterization of nanobodies targeting PSMA for molecular imaging of prostate cancer
Evazalipour, Mehdi
D'Huyvetter, Matthias
Tehrani, Bahram Soltani
Abolhassani, Mohsen
Omidfar, Kobra
Abdoli, Shahriyar
Arezumand, Roghaye
Morovvati, Hamid
Lahoutte, Tony
Muyldermans, Serge
Devoogdt, Nick
CONTRAST MEDIA & MOLECULAR IMAGING, 2014, 9 (03) : 211 - 220
[9] Imaging and therapy targeting PSMA receptors for enhanced vision and precise treatment
Rasul, Sazan
Korn, Stephan
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2023, 16 (04) : 251 - 254
[10] Imaging and therapy targeting PSMA receptors for enhanced vision and precise treatment
Sazan Rasul
Stephan Korn
memo - Magazine of European Medical Oncology, 2023, 16 : 251 - 254

← 1 2 3 4 5 →